Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Solid Tumor Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03218826
What this trial is testing

PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Prostate Carcinoma+23 more
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Study completedNCT02697591
What this trial is testing

INCAGN01876 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07723482
What this trial is testing

ML-016 in Advanced Cancer With Lung and/or Liver Involvement

Who this might be right for
Advanced Solid Tumor With Lung and/or Liver Involvement
BrYet US, Inc. 108
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631884
What this trial is testing

Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor

Who this might be right for
Solid TumorsNeoplasms (Cancer / Tumors)Advanced Malignant Solid Neoplasm+13 more
Haihua Yuan 15
Early research (Phase 1)Looking for participantsNCT07081984
What this trial is testing

Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors

Who this might be right for
HPV 16+ Recurrent or Metastatic CancerHNSCCCervical Cancer
Therorna 12
Not applicableLooking for participantsNCT04504604
What this trial is testing

TCF-001 TRACK (Target Rare Cancer Knowledge) Study

Who this might be right for
Rare CancersCholangiocarcinomaCancer of Unknown Primary Site
TargetCancer Foundation 400
Testing effectiveness (Phase 2)Looking for participantsNCT07107633
What this trial is testing

A Phase II Clinical Study to Evaluate the Efficacy and Safety of Technetium [99mtc]-H7ND Injection in the Diagnosis of Peritoneal Metastasis of Gastrointestinal Malignant Tumor.

Who this might be right for
Solid TumorPeritoneal Metastasis
Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd. 90
Early research (Phase 1)Study completedNCT01562275
What this trial is testing

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 When Administered in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Neoplasms
Genentech, Inc. 67
Very early researchNot Yet RecruitingNCT06825455
What this trial is testing

Allogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsOvarian CancersPeritoneal (metastatic) Cancer
Peking University 18
Not applicableStudy completedNCT00001397
What this trial is testing

Evaluation, Treatment, and Training for Patients With Blood Disorders

Who this might be right for
Hematologic Diseases
National Heart, Lung, and Blood Institute (NHLBI) 1,452
Early research (Phase 1)Study completedNCT02650713
What this trial is testing

The Safety, Pharmacokinetics, and Therapeutic Activity of RO6958688 in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen (CEA)-Positive Solid Tumors

Who this might be right for
Solid Tumors
Hoffmann-La Roche 228
Early research (Phase 1)Looking for participantsNCT07046923
What this trial is testing

LY4175408 in Participants With Advanced Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungSmall Cell Lung CarcinomaEndometrial Neoplasms+2 more
Eli Lilly and Company 240
Early research (Phase 1)Looking for participantsNCT06911008
What this trial is testing

MTI-301 for the Treatment of Metastatic or Unresectable and Refractory Solid Cancers

Who this might be right for
Metastatic Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
Mayo Clinic 42
Not applicableNot Yet RecruitingNCT07046780
What this trial is testing

A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor CancerMetastatic Solid TumorsLocally Advanced
PENG YUAN 90
Not applicableUnknownNCT05539183
What this trial is testing

Collection of Pleural Effusion Fluid

Who this might be right for
Solid TumorPleural EffusionMetastasis
Universitair Ziekenhuis Brussel 50
Early research (Phase 1)Study completedNCT01352962
What this trial is testing

Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

Who this might be right for
Urethral NeoplasmsNeoplasms, UrethralCancer of the Urethra+1 more
National Cancer Institute (NCI) 18
Early research (Phase 1)Looking for participantsNCT06713369
What this trial is testing

AZD5305 hADME in Patients With Advanced Solid Malignancies

Who this might be right for
Locally Advanced or Metastatic Solid Tumor
AstraZeneca 8
Early research (Phase 1)Study completedNCT00002923
What this trial is testing

KRN5500 in Treating Patients With Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Barbara Ann Karmanos Cancer Institute 27
Early research (Phase 1)Looking for participantsNCT04443088
What this trial is testing

An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors

Who this might be right for
CancerSolid Tumor, AdultCancer Metastatic+3 more
Shenzhen Ionova Life Sciences Co., Ltd. 78
Early research (Phase 1)Active Not RecruitingNCT06253520
What this trial is testing

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

Who this might be right for
Metastatic Solid CancersColorectal CancerBreast Cancer+4 more
National Cancer Institute (NCI) 210
Next Page